Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in "real‐world" administration

• Asıl Yazarlar: Ahmed M. Salem (Yazar), Erik Dvergsten (Yazar), Sanja Karovic (Yazar), Michael L. Maitland (Yazar), Mathangi Gopalakrishnan (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2023-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Taxanes are currently the most frequently used chemotherapeutic agents in cancer care, where real‐world use has focused on minimizing adverse events and standardizing the delivery. Myelosuppression is a well‐characterized, adverse pharmacodynamic effect of taxanes. Electronic health records...